AVT03, approved in Japan as DENOSUMAB BS 120 mg/1.4 mL in a vial for subcutaneous injection, is a biosimilar to Ranmark® (denosumab), which is marketed in some other countries globally as Xgeva® ...
Also listed on the HSA and FSA Stores are the Therabody JetBoots, compression boots that reduce muscle pain, increase blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback